anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Analyze Data

Slide function collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 58,039
Current window 31,651-31,680
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all
18 30 60

Slide function

31,651-31,680 of 58,039

filter-aware
37
Includes non-GAAP financial measure reconciliation.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
38
Standard non-GAAP financial reconciliation table.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
39
Standard financial reconciliation table for non-GAAP metrics.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
40
Standard financial reporting table showing year-over-year performance.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
41
The table provides a breakdown of revenue, operating expenses, and net income across three time periods (Six months ended June 30, 2022; Year ended Dec 31, 2021; Year ended Dec 31, 2020).Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
42
The table provides a breakdown of assets into consolidated, excluded, and net asset categories across three reporting periods.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
43
This is a continuation slide focusing on the liability and equity sections of the balance sheet.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
08
The slide highlights the efficacy of VYVGART in achieving IWG-defined responses in ITP patients.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
argenx SE | Results Presentation Deck | 19 slidesargenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The table shows a significant increase in R&D and SG&A expenses leading to a larger net loss compared to the previous year.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · Action1 hit
05
The slide uses a consistent 'waterfall-bridge' style annotation to show year-over-year changes between two bars.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
07
The slide uses a mix of a data table and bulleted callouts to explain the drivers behind the KPI changes.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
08
The slide uses a combination of qualitative commentary icons and a quantitative data table.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
10
The table uses a standard financial reporting format to bridge the gap between Gross Margin and Adjusted PBT Margin.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
11
The chart highlights significant outflows in working capital, tech, and supply chain investments.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
12
Data source: Zanos et al., 2016. The charts show dose-dependent reduction in immobility time.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
13
The slide uses a third-party study (Yang et al., 2015) to support the claim of a superior therapeutic index for R-ketamine.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
15
CADSS = Clinician administered dissociative states scale. Data points are clustered by time interval.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
20
The chart compares 25mg, 10mg, and 1mg (comparator) dosages. Statistical significance is marked with asterisks.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
The chart displays statistical significance markers (p-values) at Day 1, Day 2, and Day 7.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
30
Slide 30. Includes statistical significance markers (*, **, ***).ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
31
The slide uses topographical brain maps to visualize EEG data changes. Significant channels are marked with black circles.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
35
The slide uses a grouped bar chart to show T-scores across three cognitive tests (HVLT, Symbol Coding, Category Fluency) for four dosage groups.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
05
The chart shows a significant p-value of 0.018 for NfL reduction. The study design is noted as randomized, double-blind, placebo-controlled, and parallel-group.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
16
The slide highlights the therapeutic window of BAER-101 by showing efficacy in the punished model without significant impairment in the un-punished model.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Product1 hit
18
The chart shows BAER-101 regimens consistently resulting in lower sleepiness rates than Lorazepam.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
23
The slide uses bar charts to demonstrate statistical significance (p < 0.001) of the drug over placebo in two different pain models.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
02
Includes footnotes regarding reserve build, non-GAAP measures, and rounding.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · AttentionLoop · Logic Chain1 hit
04
Includes four distinct charts tracking payment volume, transaction growth, and deposit balances.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
05
The slide uses a combination of area charts to visualize delinquency volumes over time, with a callout box summarizing key performance drivers and metrics.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit